Marketing Oversight By States Creates Multiple Compliance Standards For Firms
As more and more states pass laws that require pharmaceutical companies to disclose payments to health care practitioners, there needs to be a single definition of which data must be reported, according to John Patrick Oroho, executive vice president of Porzio Pharmaceutical Services.
"It's difficult to track the information in the first place, but it's a lot more difficult when you have different definitions across the country," Oroho said in an interview.
The marketing disclosure bills introduced in nine states during 2008 contain varying reporting thresholds and exemptions, Oroho pointed out during a recent Center for Business Intelligence conference. PPS provides consulting services on federal and state regulations governing pharmaceutical marketing and sales practices.
Continue reading "Marketing Oversight By States Creates Multiple Compliance Standards For Firms " »


